CD8A and neoplasm: Conversely, the combined therapy caused a statistically significant increase in the number of CD8+ T cells (Fig. 3A) and CD80+ M1-like macrophages (Fig. 3B) and a reduction of FoxP3+ Treg (Fig. 3C) in the tumor area compared to the control group.